Visian ICL
The Visian Implantable
Collamer Lens (ICL) is a phakic intraocular lens (IOL) that is
placed between the iris and the natural lens to correct for
nearsightedness. This is a surgical procedure that will take about
15 to 30 minutes. One eye is treated at a time, and once it is
determined the first eye has healed sufficiently, the second eye may
then receive an implant. In some cases, you may need reading glasses
after surgery even if you did not need them before. Although the
Visian ICL is intended to be permanent, the lens may be removed, if
desired.
With successful use in more than 65,000 procedures worldwide, the
Visian ICL has shown to provide excellent and stable outcomes to
correct moderate to high nearsightedness, with most patients able to
achieve vision 20/40 or better. During the US FDA clinical trials,
an overwhelming majority of patients (99.4%) were satisfied three
years after the procedure.
Is the Visian ICL right for you? Your doctor will perform a series
of tests and discuss options with you to help you decide if you meet
the following criteria for having a Visian ICL procedure:
- You are between the ages of 21 and 45.
- Your nearsightedness can be corrected with lenses between -3.0
to -20.0 diopters.
- You have 2.5 diopters or less of astigmatism.
- Your eyes are stable and your nearsightedness has not changed
more than 0.50 diopters each year for at least 1 year.
- You are not currently pregnant or nursing.
Risks - Implantation of a Visian Phakic IOL is a surgical
procedure and, therefore, associated risks must be considered, which
could include infection, bleeding, blurry vision and other serious
potential complications. Patients with moderate to high levels of
nearsightedness have a higher risk for retinal detachment; this risk
level may be increased with this procedure, as well as, increased
risk for cataract development. Long-term risks include the need to
have the lens repositioned, exchanged, replaced or removed due to
conditions such as eye trauma, incorrect lens power, glare/halos or
for the treatment of other conditions such as retinal detachment,
cataract development and chronic inflammation. Details related to
the variety of treatments for potential complications should be
discussed with your ophthalmologist.
For more information please visit the following site:
http://www.visianinfo.com
|
